Coal miners, their family members, and union representatives rallied outside of the US Department of Labor’s headquarters in ...

Parkinson’s disease currently affects nearly one million Americans with no specific known cause and no cure. Treatments have ...

Gyre Pharmaceuticals has completed participant enrolment for its 52-week Phase III clinical trial assessing Pirfenidone ...

New research from the George Washington University shows the hidden toll of work injuries caused by workplace exposure to ...

Chronic dehydration is a widespread but often overlooked safety hazard in high-heat workplaces, affecting cognitive ...

Trichloroethylene (TCE) is a hazardous, chlorinated solvent that was once widely used as a medical anaesthetic, an industrial ...

Key context is missing from a widely shared social media post that suggests eating “excessive” amounts of fruit can increase the risk of coronary heart disease. The post conflates the effects of added ...

Sept 30 (Reuters) - The U.S. Food and Drug Administration has approved Novartis' (NOVN.S), opens new tab oral treatment for patients with type of chronic inflammatory skin disease, the Swiss drugmaker ...

MISSOURI, USA — Something is festering underground beneath numerous soybean fields in Missouri and Illinois. No one knows how a fungal disease called Red Crown Rot arrived in the states, and no one ...

U.S.-based Barinthus Biotherapeutics is entering a reverse merger with U.K. biotech Clywedog Therapeutics, with the combined company expected to advance three clinical assets across diabetes and ...